Genkyotex (GENK.RC)

Swiss biotech developing drugs that target NOX enzymes.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Genkyotex IPO News more
  • .
IPO Data
IPO File Date 01/07/2015
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $100
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$100
 
Underwriters
more
Business Overview
Swiss biotech developing drugs that target NOX enzymes.
Swiss biotech developing drugs that target NOX enzymes.
more
Company Data
Headquarters Geneva, , Switzerland
Founded 2006
Employees n/a
Website
 

Performance vs. IPO Index (IPOUSA)